Diagnostic ultrasound ( PDFDrive )

1240 PART IV Obstetric and Fetal Sonography
13. Bagnall KM, Harris PF, Jones PR. A radiographic study of the human fetal
spine. 2. he sequence of development of ossiication centres in the vertebral
column. J Anat. 1977;124(Pt 3):791-802.
14. Ford DM, McFadden KD, Bagnall KM. Sequence of ossiication in human
vertebral neural arch centers. Anat Rec. 1982;203(1):175-178.
15. Budorick NE, Pretorius DH, Grafe MR, Lou KV. Ossiication of the fetal
spine. Radiology. 1991;181(2):561-565.
16. Braithwaite JM, Armstrong MA, Economides DL. Assessment of fetal anatomy
at 12 to 13 weeks of gestation by transabdominal and transvaginal sonography.
Br J Obstet Gynaecol. 1996;103(1):82-85.
17. Blumenfeld Z, Siegler E, Bronshtein M. he early diagnosis of neural tube
defects. Prenat Diagn. 1993;13(9):863-871.
18. Sebire NJ, Noble PL, horpe-Beeston JG, et al. Presence of the ‘lemon’ sign
in fetuses with spina biida at the 10-14-week scan. Ultrasound Obstet
Gynecol. 1997;10(6):403-405.
19. Bernard JP, Suarez B, Rambaud C, et al. Prenatal diagnosis of neural tube
defect before 12 weeks’ gestation: direct and indirect ultrasonographic
semeiology. Ultrasound Obstet Gynecol. 1997;10(6):406-409.
20. Robbin ML, Filly RA, Goldstein RB. he normal location of the fetal conus
medullaris. J Ultrasound Med. 1994;13(7):541-546.
21. Zalel Y, Lehavi O, Aizenstein O, Achiron R. Development of the fetal spinal
cord: time of ascendance of the normal conus medullaris as detected by
sonography. J Ultrasound Med. 2006;25(11):1397-1401.
22. hiagarajah S, Henke J, Hogge WA, et al. Early diagnosis of spina biida:
the value of cranial ultrasound markers. Obstet Gynecol. 1990;76(1):
54-57.
23. Babcook CJ, Goldstein RB, Barth RA, et al. Prevalence of ventriculomegaly
in association with myelomeningocele: correlation with gestational age
and severity of posterior fossa deformity. Radiology. 1994;190(3):
703-707.
24. Watson WJ, Chescheir NC, Katz VL, Seeds JW. he role of ultrasound in
evaluation of patients with elevated maternal serum alpha-fetoprotein: a
review. Obstet Gynecol. 1991;78(1):123-128.
25. Dyson RL, Pretorius DH, Budorick NE, et al. hree-dimensional ultrasound
in the evaluation of fetal anomalies. Ultrasound Obstet Gynecol.
2000;16(4):321-328.
26. Riccabona M, Johnson D, Pretorius DH, Nelson TR. hree dimensional
ultrasound: display modalities in the fetal spine and thorax. Eur J Radiol.
1996;22(2):141-145.
27. Bonilla-Musoles F, Machado LE, Osborne NG, et al. Two- and threedimensional
ultrasound in malformations of the medullary canal: report
of four cases. Prenat Diagn. 2001;21(8):622-626.
28. Lee W, Chaiworapongsa T, Romero R, et al. A diagnostic approach for the
evaluation of spina biida by three-dimensional ultrasonography. J Ultrasound
Med. 2002;21(6):619-626.
29. Schild RL, Wallny T, Fimmers R, Hansmann M. he size of the fetal thoracolumbar
spine: a three-dimensional ultrasound study. Ultrasound Obstet
Gynecol. 2000;16(5):468-472.
30. Johnson DD, Pretorius DH, Riccabona M, et al. hree-dimensional ultrasound
of the fetal spine. Obstet Gynecol. 1997;89(3):434-438.
31. Wax JR, Watson WJ, Miller RC, et al. Prenatal sonographic diagnosis of
hemivertebrae: associations and outcomes. J Ultrasound Med.
2008;27(7):1023-1027.
32. Kalache KD, Bamberg C, Proquitte H, et al. hree-dimensional multi-slice
view: new prospects for evaluation of congenital anomalies in the fetus.
J Ultrasound Med. 2006;25(8):1041-1049.
33. Merce LT, Barco MJ, Bau S. hree-dimensional volume sonographic study
of fetal anatomy: intraobserver reproducibility and efect of examiner
experience. J Ultrasound Med. 2008;27(7):1053-1063.
34. Gindes L, Benoit B, Pretorius DH, Achiron R. Abnormal number of fetal
ribs on 3-dimensional ultrasonography: associated anomalies and outcomes
in 75 fetuses. J Ultrasound Med. 2008;27(9):1263-1271.
35. Volcik KA, Blanton SH, Tyerman GH, et al. Methylenetetrahydrofolate
reductase and spina biida: evaluation of level of defect and maternal genotypic
risk in Hispanics. Am J Med Genet. 2000;95(1):21-27.
36. Li Z, Ren A, Zhang L, et al. Extremely high prevalence of neural tube
defects in a 4-county area in Shanxi Province, China. Birth Defects Res A
Clin Mol Teratol. 2006;76(4):237-240.
37. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly
and spina biida and the impact of prenatal diagnosis—United States,
1985-1994. MMWR CDC Surveill Summ. 1995;44(4):1-13.
38. EUROCAT Working Group. Prevalence of neural tube defects in 20 regions
of Europe and the impact of prenatal diagnosis, 1980-1986. EUROCAT
Working Group. J Epidemiol Community Health. 1991;45(1):52-58.
39. Laurence KM, James N, Miller MH, et al. Double-blind randomised controlled
trial of folate treatment before conception to prevent recurrence of neuraltube
defects. Br Med J (Clin Res Ed). 1981;282(6275):1509-1511.
40. MRC Vitamin Study Research Group. Prevention of neural tube defects:
results of the Medical Research Council Vitamin Study. MRC Vitamin
Study Research Group. Lancet. 1991;338(8760):131-137.
41. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure
and risk of occurrent neural tube defects. JAMA. 1993;269(10):
1257-1261.
42. Czeizel AE. Prevention of congenital abnormalities by periconceptional
multivitamin supplementation. BMJ. 1993;306(6893):1645-1648.
43. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation
with folate and/or multivitamins for preventing neural tube defects. Cochrane
Database Syst Rev. 2000;(2):CD001056.
44. Recommendations for the use of folic acid to reduce the number of cases
of spina biida and other neural tube defects. MMWR Recomm Rep.
1992;41(RR-14):1-7.
45. Great Britain, Department of Health, et al. Folic acid and the prevention
of neural tube defects: report from an expert advisory group. London:
Department of Health; 1992.
46. Kadir RA, Sabin C, Whitlow B, et al. Neural tube defects and periconceptional
folic acid in England and Wales: retrospective study. BMJ. 1999;319(7202):
92-93.
47. Rosano A, Smithells D, Cacciani L, et al. Time trends in neural tube defects
prevalence in relation to preventive strategies: an international study. J
Epidemiol Community Health. 1999;53(10):630-635.
48. Sharpe G, Young G. Folic acid and the prevention of neural tube defects.
Most pregnant women do not take folic acid. BMJ. 1995;311(6999):256.
49. Wild J, Sutclife M, Schorah CJ, Levene MI. Prevention of neural-tube
defects. Lancet. 1997;350(9070):30-31.
50. Huttly WJ, Wald NJ, Walters JC. Folic acid supplementation before pregnancy
remains inadequate. BMJ. 1999;319(7223):1499.
51. Honein MA, Paulozzi LJ, Mathews TJ, et al. Impact of folic acid fortiication
of the US food supply on the occurrence of neural tube defects. JAMA.
2001;285(23):2981-2986.
52. Persad VL, Van den Hof MC, Dubé JM, Zimmer P. Incidence of open
neural tube defects in Nova Scotia ater folic acid fortiication. CMAJ.
2002;167(3):241-245.
53. Forrester MB, Merz RD. Descriptive epidemiology of lipomyelomeningocele,
Hawaii, 1986-2001. Birth Defects Res A Clin Mol Teratol. 2004;70(12):
953-956.
54. De Wals P, Van Allen MI, Lowry RB, et al. Impact of folic acid food fortiication
on the birth prevalence of lipomyelomeningocele in Canada. Birth
Defects Res A Clin Mol Teratol. 2008;82(2):106-109.
55. Main DM, Mennuti MT. Neural tube defects: issues in prenatal diagnosis
and counselling. Obstet Gynecol. 1986;67(1):1-16.
56. Lescale KB, Eddleman KA, Chervenak FA. he fetal neck and spine. In:
McGahan JP, Porto M, editors. Diagnostic obstetrical ultrasound. Philadelphia:
Lippincott; 1994. p. 195.
57. Ray JG, Wyatt PR, hompson MD, et al. Vitamin B12 and the risk of neural
tube defects in a folic-acid-fortiied population. Epidemiology. 2007;18(3):
362-366.
58. Babcook CJ, Goldstein RB, Filly RA. Prenatally detected fetal myelomeningocele:
is karyotype analysis warranted? Radiology. 1995;194(2):
491-494.
59. Sepulveda W, Corral E, Ayala C, et al. Chromosomal abnormalities in fetuses
with open neural tube defects: prenatal identiication with ultrasound.
Ultrasound Obstet Gynecol. 2004;23(4):352-356.
60. Byrne J, Warburton D. Neural tube defects in spontaneous abortions. Am
J Med Genet. 1986;25(2):327-333.
61. Gregerson DM. Clinical consequences of spina biida occulta. J Manipulative
Physiol her. 1997;20(8):546-550.